New treatment for common form of muscular dystrophy shows promise in cells, animals – University of Alberta

U of A medical geneticist Toshifumi Yokota led a research team that created a potential new treatment for one of the most common forms of muscular dystrophy. (Photo: Supplied)

 
Researchers have designed a potential new treatment for one of the most common forms of muscular dystrophy, according to a new study published in the Proceedings of the National Academy of Sciences.

Toshifumi Yokota, professor of medical genetics at the University of Alberta, led a team from Canada and the U.S. to create and test synthetic DNA-like molecules that interfere with the production of a toxic protein that destroys the muscles of people who have facioscapulohumeral muscular dystrophy (FSHD).

Click here to read full article https://www.folio.ca/new-treatment-for-common-form-of-muscular-dystrophy-shows-promise-in-cells-animals

Share

Leave a Reply

Your email address will not be published. Required fields are marked *

Font Resize